15-min delayed · Jul 28, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 1 firms covering Incannex Healthcare Ltd ADR, 1 rate it Buy or better, 0 sit at Hold, and 0 rate it Sell or worse, a moderate buy consensus. Targets are tightly clustered, $18.00 to $18.00, so the covering firms are broadly aligned. The average target of $18.00 sits 512% above the current $2.94. The rating mix has held broadly steady over recent months. On the fundamentals, the Street sees consensus EPS building from about $-0.51 next quarter toward $-2.40 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS1 ratings
Moderate Buy
Strong Buy00%
Buy1100%
Hold00%
Sell00%
Strong Sell00%
Based on 1 analysts giving stock ratings to Incannex Healthcare Ltd ADR.
As of Jul, 1 of 1 firms rate IXHL a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
IXHL EPS & revenue forecast
EPS · NEXT QUARTER
$-0.51
Range $-0.51 – $-0.51 · 1 analysts
Next period, 1 analysts expect Incannex Healthcare Ltd ADR to earn $-0.51 a share (range $-0.51 – $-0.51), versus — a year earlier. , growing to $-2.40 the year after.
REVENUE · NEXT QUARTER
$0
Range $0 – $0 · 1 analysts
Revenue is expected to reach $0 (range $0 – $0)., rising to $0 next year.
Top analysts covering Incannex Healthcare Ltd ADR
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on IXHL.
#1
James Molloy
Alliance Global Partners · Rank #385
Buy
$18.00+512.2% to target
Overall win rate
25%
+ Follow
IXHL stock forecast FAQ
What is IXHL's average 12-month price target?+
The 1 analysts with a live target average $18.00 for Incannex Healthcare Ltd ADR over the next 12 months, ranging from a $18.00 high to a $18.00 low.
Is IXHL stock a Buy, Sell or Hold right now?+
The current consensus is Moderate Buy. Of the 1 analyst ratings, 1 are Buy or Strong Buy, 0 are Hold, and 0 are Sell or Strong Sell.
How many Wall Street analysts cover IXHL?+
1 analysts have an active rating on Incannex Healthcare Ltd ADR, and 1 firms carry a live 12-month price target.
Who is the most accurate analyst covering IXHL?+
Among analysts who currently cover IXHL, James Molloy of Alliance Global Partners has the strongest overall Quantellect track record (Rank #385). Their current call is Buy with a $18.00 target.
What is Incannex Healthcare Ltd ADR's projected EPS for next quarter?+
The consensus estimate is $-0.51 per share (range $-0.51 – $-0.51) across 1 analysts, rising to $-2.40 the following year.
How much revenue is Incannex Healthcare Ltd ADR expected to report next quarter?+
Consensus revenue is $0 (range $0 – $0), growing to $0 next year.
Have analysts been upgrading or downgrading IXHL lately?+
As of Jul, 1 of 1 firms rate IXHL a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their IXHL calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
